Localized translation of cytoskeletal proteins in axonal morphogenesis

细胞骨架蛋白在轴突形态发生中的局部翻译

基本信息

  • 批准号:
    8661318
  • 负责人:
  • 金额:
    $ 33.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The formation of axon collateral branches underlies the ability of neurons to make synaptic contacts with multiple target neurons and thus give rise to complex neuronal networks. In the context of nervous system injury, the formation of axon collateral branches can have either beneficial or undesired effects depending on the affected circuitry. Collateral branches are also affected by a variety of disease states. However, the cellular mechanisms of collateral branching are only minimally understood. The preliminary data presented in this proposal unveils for the first time that the branch-inducing signal nerve growth factor drives the intra-axonal synthesis of cytoskeletal proteins with roles in the formation of collateral branches. Importantly, the preliminary data also demonstrate that axonal protein synthesis is required for the induction of axon collateral branching by nerve growth factor. Although recent studies have revealed a large set of mRNAs targeted to axons, the functional roles of the axonal translation of axonal mRNAs remains minimally understood. The main aim of the proposal is to determine the roles of the axonal synthesis of individual cytoskeletal proteins in the formation of axon collateral branches. By bridging the expertise of the PI (Dr. Gallo; neuronal cytoskeletal cell biology) and the Co-I (Dr. Twiss; axonal protein synthesis), the project provides the unique opportunity to uncover a new aspect of the mechanism of axon branching and aims to directly link the axonal synthesis of specific cytoskeletal proteins to the regulation f the dynamics of the axonal cytoskeleton. Through the joint expertise of the PI and Co-I, the project takes a multi-pronged in vivo and in vitro approach to address the main Aims. Collateral branching is affected by nervous system injury and disease. However, the ability to manipulate branching in a therapeutic context is mostly lacking. The project has the potential to lead to strategies for the regulation of axon branching by targeting specific axonal mRNA species in the context of neuronal injury and disease. The reagents developed for use in the project (e.g., cell permeable tools to selectively inhibit the axonal translation of individual mRNA species) have the potential for translation to animal model system of collateral branching in future directions o the project. The work we propose will serve as the foundation for these long term goals by determining the relevant mRNA targets through the elucidation of their roles in branching.
描述(申请人提供):轴突侧支的形成是神经元与多个目标神经元进行突触接触的能力的基础,从而产生复杂的神经元网络。在神经系统损伤的情况下,轴突侧支的形成可能有有益的影响,也可能有不良的影响,这取决于受影响的电路。抵押品分支也会受到各种疾病状态的影响。然而,侧支分支的细胞机制还知之甚少。这项提案中提供的初步数据首次揭示了分支诱导信号神经生长因子驱动轴突内细胞骨架蛋白的合成,并在侧枝的形成中发挥作用。重要的是,初步数据还表明,轴突蛋白质合成是神经生长因子诱导轴突侧支分支所必需的。尽管最近的研究揭示了大量针对轴突的mRNAs,但轴突mRNAs轴突翻译的功能作用仍然知之甚少。该提案的主要目的是确定单个细胞骨架蛋白的轴突合成在轴突侧支形成中的作用。通过将PI(加洛博士;神经元细胞骨架细胞生物学)和Co-I(Twiss博士;轴突蛋白质合成)的专业知识联系起来,该项目 为揭示轴突分支机制的新方面提供了独特的机会,旨在将特定细胞骨架蛋白的轴突合成与轴突细胞骨架动力学的调节直接联系起来。通过PI和Co-I的联合专业知识,该项目采取了体内和体外多管齐下的方法来解决主要目标。侧支分支受神经系统损伤和疾病的影响。然而,在治疗的背景下操纵分支的能力大多是缺乏的。该项目有可能导致通过在神经元损伤和疾病的背景下针对特定的轴突mRNA物种来调节轴突分支的策略。为该项目开发的试剂(例如,选择性抑制单个mRNA物种轴突翻译的细胞渗透性工具)有可能在该项目未来的方向转化为侧支分支的动物模型系统。我们提出的工作将作为这些长期目标的基础,通过阐明它们在分支中的作用来确定相关的mRNA靶标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GIANLUCA GALLO其他文献

GIANLUCA GALLO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GIANLUCA GALLO', 18)}}的其他基金

Mechanism of nerve growth factor driven axon plasticity
神经生长因子驱动轴突可塑性机制
  • 批准号:
    10626679
  • 财政年份:
    2022
  • 资助金额:
    $ 33.77万
  • 项目类别:
The Role of Glycolysis in Axon Development
糖酵解在轴突发育中的作用
  • 批准号:
    10040537
  • 财政年份:
    2020
  • 资助金额:
    $ 33.77万
  • 项目类别:
Localized translation of cytoskeletal proteins in axonal morphogenesis
细胞骨架蛋白在轴突形态发生中的局部翻译
  • 批准号:
    9069088
  • 财政年份:
    2013
  • 资助金额:
    $ 33.77万
  • 项目类别:
Localized translation of cytoskeletal proteins in axonal morphogenesis
细胞骨架蛋白在轴突形态发生中的局部翻译
  • 批准号:
    8577831
  • 财政年份:
    2013
  • 资助金额:
    $ 33.77万
  • 项目类别:
Mechanisms of filopodia initiation and actin transport
丝状伪足起始和肌动蛋白运输机制
  • 批准号:
    7341665
  • 财政年份:
    2004
  • 资助金额:
    $ 33.77万
  • 项目类别:
Mechanisms of filopodia initiation and actin transport
丝状伪足起始和肌动蛋白运输机制
  • 批准号:
    8088996
  • 财政年份:
    2004
  • 资助金额:
    $ 33.77万
  • 项目类别:
Mechanisms of filopodia initiation and actin transport
丝状伪足起始和肌动蛋白运输机制
  • 批准号:
    7156952
  • 财政年份:
    2004
  • 资助金额:
    $ 33.77万
  • 项目类别:
Mechanisms of filopodia initiation and actin transport
丝状伪足起始和肌动蛋白运输机制
  • 批准号:
    6877620
  • 财政年份:
    2004
  • 资助金额:
    $ 33.77万
  • 项目类别:
Mechanisms of filopodia initiation and actin transport
丝状伪足起始和肌动蛋白运输机制
  • 批准号:
    6989085
  • 财政年份:
    2004
  • 资助金额:
    $ 33.77万
  • 项目类别:
Mechanisms of filopodia initiation and actin transport
丝状伪足起始和肌动蛋白运输机制
  • 批准号:
    7540978
  • 财政年份:
    2004
  • 资助金额:
    $ 33.77万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了